Screening for Familial Intracranial Aneurysms. Decision and Cost-effectiveness Analysis

Academic Radiology

Volumn 15, Issue 4, 2008, Pages 462-471

  Takao, Hidemasa ^a   Nojo, Takeshi ^b   Ohtomo, Kuni ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aneurysm; magnetic resonance angiography; screening; subarachnoid hemorrhage

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANEURYSM RUPTURE; ANTERIOR CEREBRAL ARTERY; ANTERIOR COMMUNICATING ARTERY; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; ENDOVASCULAR SURGERY; FAMILY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; INTRACRANIAL ANEURYSM; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; OUTCOME ASSESSMENT; POSTERIOR COMMUNICATING ARTERY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 40649102674     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.11.007     Document Type: Article

References (34)

1. Rinkel G.J.E., Djibuti M., Algra A., et al. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 29 (1998) 251-256
2. Rinkel G.J.E. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol 4 (2005) 122-128
3. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362 (2003) 103-110
4. Bederson J.B., Awad I.A., Wiebers D.O., et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 31 (2000) 2742-2750
5. Crawley F., Clifton A., and Brown M.M. Should we screen for familial intracranial aneurysm?. Stroke 30 (1999) 312-316
6. The Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage. N Engl J Med 341 (1999) 1344-1350
7. Doubilet P., Begg C.B., Weinstein M.C., et al. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 5 (1985) 157-177
8. Takao H., and Nojo T. Treatment of unruptured intracranial aneurysms: decision and cost-effectiveness analysis. Radiology 244 (2007) 755-766
9. White P.M., Wardlaw J.M., and Easton V. Can noninvasive imaging accurately depict intracranial aneurysms?. A systematic review. Radiology 217 (2000) 361-370
10. Cloft H.J., Joseph G.J., and Dion J.E. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 30 (1999) 317-320
11. Vindlacheruvu R.R., Mendelow A.D., and Mitchell P. Risk-benefit analysis of the treatment of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 76 (2005) 234-239
12. Mitchell P., Gholkar A., Vindlacheruvu R.R., et al. Unruptured intracranial aneurysms: benign curiosity or ticking bomb?. Lancet Neurol 3 (2004) 85-92
13. US Department of Health and Human Services, and Centers for Disease Control and Prevention. http://www.cdc.gov Accessed February 15, 2006
14. Johnston S.C., Gress D.R., and Kahn J.G. Which unruptured cerebral aneurysms should be treated?. A cost-utility analysis. Neurology 52 (1999) 1806-1815
15. Hop J.W., Rinkel G.J.E., Algra A., et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systemic review. Stroke 28 (1997) 660-664
16. Mayer S.A., Kreiter K.T., Copeland D., et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 59 (2002) 1750-1758
17. Kreiter K.T., Copeland D., Bernardini G.L., et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 33 (2002) 200-209
18. Ronkainen A., Niskanen M., Rinne J., et al. Evidence for excess long-term mortality after treated subarachnoid hemorrhage. Stroke 32 (2001) 2850-2853
19. Strauss D.J., Shavelle R.M., and Anderson T.W. Long-term survival of children and adolescents after traumatic brain injury. Arch Phys Med Rehabil 79 (1998) 1095-1100
20. Wiebers D.O. Patients with small, asymptomatic, unruptured intracranial aneurysms and no history of subarachnoid hemorrhage should generally be treated conservatively. Stroke 36 (2005) 408-409
21. Post P.N., Kievit J., van Baalen J.M., et al. Routine duplex surveillance does not improve the outcome after carotid endarterectomy: a decision and cost utility analysis. Stroke 33 (2002) 749-755
22. Gage B.F., Cardinalli A.B., Albers G.W., et al. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 274 (1995) 1839-1845
23. US Department of Labor, and Bureau of Labor Statistics. http://www.bls.gov Accessed March 6, 2006
24. Huang J. van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 51 (2002) 1101-1107
25. Post P.N., Stiggelbout A.M., and Wakker P.P. The utility of health states after stroke: a systematic review of the literature. Stroke 32 (2001) 1425-1429
26. Aoki N., Beck J.R., Kitahare T., et al. Reanalysis of unruptured intracranial aneurysm management: effect of a new international study on the threshold probabilities. Med Decis Making 21; (2001) 87-96
27. King Jr. J.T., Glick H.A., Mason T.J., et al. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J Neurosurg 83 (1995) 403-412
28. Hunink M.G.M., Glasziou P.P., Siegel J.E., et al. Decision making in health and medicine: integrating evidence and values (2001), Cambridge University Press, Cambridge
29. Gold M.R., Siegel J.E., Russell L.B., et al. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
30. Drummond M.F., Sculpher M.J., Torrance G.W., et al. Methods for the economic evaluation of health care programmes (2005), Oxford University Press, New York
31. TreeAge Pro 2006 user's manual (2006), TreeAge Software, Inc, Williamstown, MA
32. Yoshimoto Y., and Wakai S. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms: a mathematical model. Stroke 30 (1999) 1621-1627
33. Butler W.E., Barker II F.G., and Crowell R.M. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracranial aneurysms: a decision analysis. Neurosurgery 38 (1996) 506-516
34. Wermer M.J.H., Buskens E., van der Schaaf I.C., et al. Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage. Neurology 62 (2004) 369-375